News Search Results
Nov 05, 2026, 16:05 ET 10x Genomics Reports Third Quarter 2026 Financial Results
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Nov 02, 2026, 09:00 ET 10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium Analysis
10xgenomics.com.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Oct 27, 2026, 16:05 ET 10x Genomics to Participate in the 2026 Jefferies Global Healthcare Conference
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Oct 13, 2026, 16:05 ET 10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Oct 07, 2026, 09:00 ET 10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Sep 29, 2026, 09:01 ET 10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Sep 29, 2026, 09:00 ET 10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Sep 28, 2026, 09:07 ET Microfluidics Market to Reach US$ 43 Bn by 2031, Growing at 9.8% CAGR as Point-of-Care and Organ-on-Chip Adoption Expands: New Report by Wissen Research
Diagnostics and point-of-care testing10x Genomics (US)Single-cell analysis platforms
More news about: Wissen Research LLC
Sep 10, 2026, 09:00 ET Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Research
fight against cancer. Learn more at lunit.io.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: Lunit
Aug 28, 2026, 14:38 ET 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Aug 06, 2026, 16:02 ET 10x Genomics Reports Second Quarter 2026 Financial Results
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Aug 06, 2026, 10:30 ET Multiomics Market worth $5.70 billion by 2031 - Exclusive Report by MarketsandMarkets™
Multiomics companies include 10x Genomics, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bruker Corporation (US), Agilent Technologies, Inc. (US), Danaher Corporation
More news about: MarketsandMarkets
Jul 29, 2026, 09:00 ET 10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
clinical reporting frameworks to support personalized treatment planning and molecular tumor board decision-making.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jul 15, 2026, 16:05 ET 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jul 09, 2026, 10:46 ET Global Pharmacogenomic Testing Service Market to Register Stunning Growth at a CAGR of ~12% by 2034 | DelveInsight
BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Polymerase Chain Reaction, Inc., and others.
More news about: DelveInsight Business Research, LLP
Jul 02, 2026, 10:46 ET Global DNA Diagnostics Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2034 | DelveInsight
BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Polymerase Chain Reaction, Inc., and others.
More news about: DelveInsight Business Research, LLP
Jun 17, 2026, 09:00 ET 10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
advance the scientific understanding of treatment response in bladder cancer and support future diagnostic applications.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jun 12, 2026, 06:02 ET 12 Press Releases You Need to See This Week
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech GroupThe acquisition builds on 10x's broader vision to enable multimodal biological
More news about: PR Newswire
Jun 09, 2026, 09:00 ET 10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
advance human health.The terms of the transaction were not disclosed. 10x Genomics believes the transaction will not meaningfully impact its near-term financial outlook.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery
More news about: 10x Genomics, Inc.
Jun 03, 2026, 08:00 ET Zifo to Present Biobank Data Breakthrough at the Festival of Genomics Boston
https://zifornd.com/news/zifo-and-maze-therapeutics-partner-to-power-precision-medicine/Unveiling a 10x Leap in Genomics ArchitectureThe centerpiece of Zifo's agenda partnership is a highly anticipated presentation on the Biopharma Data Management Stage,
More news about: Zifo